Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aberrant Dyskerin Expression Is Related to Proliferation and Poor Survival in Endometrial Cancer

13 Jan 2021

Abstract excerpt

Dyskerin is a core-component of the telomerase holo-enzyme, which elongates telomeres. Telomerase is involved in endometrial epithelial cell proliferation. Most endometrial cancers (ECs) have high telomerase activity; however, dyskerin expression in human healthy endometrium or in endometrial pathologies has not been investigated yet. We aimed to examine the expression, prognostic relevance, and functional role...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Telomeres, Telomerase, and Senescence

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33450922
DOI: 10.3390/cancers13020273

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aberrant Dyskerin Expression Is Related to Proliferation and Poor Survival in Endometrial CancerPMID 33450922Read ↗

Endometriosis Is Associated with a Significant Increase in hTERC and Altered Telomere/Telomerase Associated Genes in the Eutopic Endometrium, an Ex-Vivo and In Silico StudySemantic proximity Read ↗

Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinomaSemantic proximity Read ↗

A pan-cancer analysis of Dyskeratosis congenita 1 (DKC1) as a prognostic biomarkerSemantic proximity Read ↗

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB PathwaysSemantic proximity Read ↗

A pan-cancer analysis of Dyskeratosis congenita 1 (DKC1) as a prognostic biomarkerSemantic proximity Read ↗

Dyskerin Overexpression in Human Hepatocellular Carcinoma Is Associated with Advanced Clinical Stage and Poor Patient PrognosisSemantic proximity Read ↗

Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial CancerSemantic proximity Read ↗

Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancerSemantic proximity Read ↗

Telomerase-independence function of Dyskerin is therapeutic vulnerability in p53 mutant pancreatic neuroendocrine tumorsSemantic proximity Read ↗

BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with ImmunitySemantic proximity Read ↗

<i>MYC</i> -Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of DyskerinSemantic proximity Read ↗

KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.